---

 

NICE Clinical Guideline 82

Schizophrenia (update): the treatment and management of schizophrenia in adults The recommendations from NICE cover: key priorities for implementation including: access and engagement primary care and physical health psychological and pharmacological interventions working in partnership with carers interventions for people with schizophrenia whose illness has not responded adequately to treatment treatment of the acute episode.

Web address: www.nice.org.uk/Guidance/CG82

NICE Clinical Guideline 83

Critical illness rehabilitation The recommendations from NICE cover: assessment and management during the critical care stay key principles of care including: reviewing and updating the short- and medium-term rehabilitation goals throughout the patient’s rehabilitation care pathway ensuring information is communicated to other healthcare settings as appropriate the functional reassessment 2–3 months after discharge by primary/community care.

Web address: www.nice.org.uk/Guidance/CG83

NICE Technology Appraisal 169

Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma Summary: Sunitinib is recommended as a first-line treatment for patients with advanced and/or metastatic renal cell carcinoma if both the following apply: immunotherapy would be suitable for them they are mobile enough to do light housework or office work patients already on sunitinib before the guidance was issued should be allowed to continue with this treatment until they and their clinician decide they should stop.

Web address: www.nice.org.uk/Guidance/TA169